-
-
-
-
-
-
-
Pacira BioSciences Announces New National Survey Revealing the Hidden Toll of Pain on America’s Workforce
-
-
-
-
-
-
-
Pacira BioSciences stockholders elect all three director nominees
-
-
-
-
-
-
-
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote “FOR” All of Pacira’s Director Nominees
-
-
-
-
-
-
-
Pacira BioSciences urges shareholders to vote for board nominees
-
-
-
-
-
-
-
Pacira BioSciences Files Definitive Proxy Materials and Mails Letter to Shareholders
-
-
-
-
-
-
-
Pacira BioSciences Reports Fourth Quarter and Full-Year 2025 Financial Results
-
-
-
-
-
-
-
Pacira BioSciences reports $726.4 million revenue for 2025
-
102,924 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


